Clinica Baviera (CBAV.MC) Stock Price
Clinica Baviera Price
Revenue has compounded at 8.5% per year over the past 19 years to 301.78 M EUR. Earnings per share have grown at 10.7% per year over the last 17 years. Clinica Baviera's net margin stands at 13.9%, down from 16.2% several years earlier. Clinica Baviera currently offers a dividend yield of about 2.95%. The payout ratio is around 67% of earnings. The dividend has grown at 7.4% per year over the past 17 years. Analysts set a median price target of 61.20 EUR, implying 15.0% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Clinica Baviera stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Clinica Baviera business model & stock analysis
Frequently asked questions about Clinica Baviera
The main competitors of Clinica Baviera SA in the market include companies such as Opticalia, EuroEyes, and Ocular Sciences. These competitors also operate in the ophthalmology sector and provide similar services and products as Clinica Baviera SA. It is important for investors and potential customers to consider the offerings and market position of these competitors when assessing Clinica Baviera SA's market share and potential growth opportunities.
Clinica Baviera SA is a renowned company operating in the healthcare sector. The business model of Clinica Baviera SA revolves around providing high-quality medical services, specializing in ophthalmology. The company offers a range of eye care treatments, including laser refractive surgery, cataract surgery, and other specialized ophthalmic procedures. Clinica Baviera SA's focus on innovation, state-of-the-art technology, and highly trained medical professionals makes them a leading player in the field. By prioritizing patients' well-being and delivering exceptional outcomes, Clinica Baviera SA has established itself as a trusted name in the eye care industry.
Clinica Baviera SA is primarily active in the healthcare industry.
Clinica Baviera SA is a renowned company in the healthcare industry. It was established in 1989 and has since become a leading provider of ophthalmology services. The company specializes in refractive surgery, especially laser-assisted techniques like LASIK. With over 85 clinics across Europe, Clinica Baviera SA has a strong presence in countries such as Spain, Germany, Italy, and Austria. The company's success can be attributed to its team of highly skilled and experienced ophthalmologists, state-of-the-art technology, and commitment to delivering exceptional patient care. Clinica Baviera SA's continuous growth and expansion reflect its dedication to offering top-quality eye care solutions to individuals seeking improved vision.
Clinica Baviera SA has achieved several significant milestones over the years. One notable achievement is its establishment as a leading provider of ophthalmological services in Spain and Italy. Additionally, the company successfully expanded its operations to other European countries, including Germany, Austria, and Portugal. Clinica Baviera SA has also gained recognition for its cutting-edge technology and innovative treatment options, ensuring high-quality care for its patients. Moreover, the company's commitment to excellence has earned it numerous industry accolades and awards. Overall, Clinica Baviera SA continues to make strides in the field of ophthalmology, solidifying its position as a trusted and reputable healthcare provider.
Clinica Baviera SA is primarily present in Spain, where its headquarters and a majority of its clinics are located. The company has a strong presence across various regions in Spain, such as Catalonia, Andalusia, Madrid, Valencia, and Galicia. With over 25 years of experience, Clinica Baviera SA is a leading ophthalmology group in Spain, providing advanced eye care services. Its expertise, state-of-the-art technology, and commitment to patient satisfaction have earned the company a reputable position in the Spanish healthcare industry.
Clinica Baviera SA represents values such as excellence, innovation, and patient-centric care. With a strong corporate philosophy, the company is committed to providing top-quality medical services and advanced eye care treatments. Clinica Baviera focuses on customer satisfaction and takes pride in offering state-of-the-art facilities and cutting-edge technology to ensure the best outcomes for their patients. As a leader in the ophthalmology field, Clinica Baviera SA continuously strives for excellence and maintains a reputation for delivering exceptional eye care services with a patient-first approach.
Analysts currently set an average price target of 61.20 EUR for the Clinica Baviera stock (median: 61.20 EUR), implying +15.0 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Clinica Baviera stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Clinica Baviera to generate revenue of 331.00 M EUR and earnings per share of 2.56 EUR.
The Clinica Baviera share (CBAV.MC) is listed on 7 stock exchanges, including: London (0GWJ.L), SIX (Zürich) (D9Z.SW), Frankfurt (D9Z.F), München (D9Z.MU), Düsseldorf (D9Z.DU), Madrid (CBAV.MC).
Clinica Baviera SA is a European company specialized in the treatment of vision problems. It was founded in Madrid in 2004 and is now present in Spain, Germany, Austria, Portugal, and Italy. The company offers various services, such as vision tests, eye corrections, and laser treatments. The focus is on outpatient surgical procedures, using state-of-the-art technologies such as the femtosecond laser for vision correction or the SLT laser for glaucoma treatment. Another important area for the company is cataract surgery, replacing the cloudy eye lens with an artificial lens. They also provide treatment for macular degeneration. In addition to surgical procedures, Clinica Baviera also offers non-invasive treatment methods, including the use of contact lenses or glasses. The company places high importance on the quality of its services and comprehensive patient care. Individualized consultation and accurate diagnosis are crucial before each treatment. To ensure this high quality, the company relies on a close network of specialists and doctors. Collaboration with reputable eye clinics and centers allows for expert advice on challenging cases. Research and development are also a key focus of the company. New procedures and technologies in the field of ophthalmology are developed and tested. Collaborations with scientific institutions are part of Clinica Baviera's research program. To promote its services, Clinica Baviera employs a wide marketing strategy. The company is present at trade fairs and conferences and maintains a strong online presence. It particularly utilizes social networks like Facebook and Instagram to showcase its services in an engaging and informative manner. In summary, Clinica Baviera offers a wide range of services in the field of ophthalmology. The company utilizes advanced technologies and strives for high-quality services. Through comprehensive patient care and extensive research, Clinica Baviera aims to remain a leading company in ophthalmology and continue evolving.
The expected revenue of Clinica Baviera is 331.00 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Clinica Baviera is 46.16 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Clinica Baviera is currently 20.76. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Clinica Baviera stock.
The price-to-sales ratio (P/S) of Clinica Baviera is currently 2.90. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Clinica Baviera stock.
The Eulerpool Quality Score for Clinica Baviera is 10/10.
The ISIN of Clinica Baviera is ES0119037010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Clinica Baviera is A0MNAP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Clinica Baviera is CBAV.MC. The ticker symbol is used to trade Clinica Baviera shares on the stock exchange.
Clinica Baviera stock
Clinica Baviera Peer Group
Clinica Baviera Ticker
Clinica Baviera FIGI
All fundamentals and in-depth analysis of Clinica Baviera
Our stock analysis for Clinica Baviera stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clinica Baviera. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.